The U.S. government has doled out more than $75 billion for oncology research since 1971.Cancer is the second leading cause of death in the USA and UK and it is estimated that one half of all men and one third of all women in those countries will develop cancer at some time during their lives. There is no total and complete cure for cancer although in some cases the cancer will go into a partial or complete remission. With no definitive cure yet available, the development of newer Anti-cancerous agents to treat cancer continues to remain a major public health dilemma worldwide. Anti-cancerous Treatment methodologies can be expensive, debilitating and sometimes intolerable.
All cancers begin in cells, the body's basic unit of life. Normal body cells grow, divide and then die in an orderly fashion. What makes cancer cells different is that they continue to grow and divide and instead of dying they outlive the normal cells and continue to form new abnormal cells. Cancer cells are thought to develop because of damage to a person’s DNA and in most cases when DNA becomes damaged the body is able to repair it, but this is not the case with cancer cells. Early detection and advanced treatment are responses to cancer. They are not prevention. Prevention involves looking at the underlying causes of the epidemic and doing what needs to be done to stop it.
Looking at the above difficulties against the cancer treatment and the changes observed at the DNA level in plants and bacterias, Guruji decided to observe the impact of his energy on Endometrium & Prostate cancerous cell lines. These experiments were carried out in the Department of laboratory medicine (RIA) of P.D. Hinduja National Hospital & Medical Research Centre, Mumbai, India– accredited by The College of American Pathologists.
These 2 cancerous cell lines were handed over to Guruji in sealed tubes by the consultant of the said department. Before Guruji treated (blessed) the tubes through his thought intervention, they were analyzed and the values have been mentioned as control in the given reports.
After Guruji’s blessings, as expected, few parameters showed significant changes that are discussed herewith and are also compared with the control, which is presented in a tabular form.
1) Tumor necrosis factor-alpha (TNF-A)
Tumor necrosis factor alpha (TNF-alpha), is a multifunctional cytokine playing a key role in cell death and cell survival as well as in inflammation and immunity. Besides extravasation of erythrocytes and lymphocytes, leading to hemorrhagic necrosis, TNF-alpha targets the tumor-associated vasculature (TAV) in cancer by inducing hyperpermeability and destruction of the vascular lining. This results in an immediate effect of selective accumulation of cytostatic drugs inside the tumor and a late effect of destruction of the tumor vasculature.Tumor necrosis factor alpha (TNF ) elicits a broad spectrum of cellular responses including cell proliferation and differentiation, inflammation and cell death. TNF increases susceptibility to heat-induced cell death (apoptosis) in a time dependent manner, an important protective cellular activity.
In the treated cell lines, the same factor has been increased by 385% when compared with the control.
2) Interleukin-6 (IL-6)
Interleukin-6 is a pleiotropic cytokine which exerts biological activities on various cell types including cancerous cells. Interleukin 6 (IL-6) is a cytokine that regulates not only immune and inflammatory responses but also the growth of some tumors, including prostate carcinomas. Serum IL-6 was significantly correlated with the clinical stage of prostate cancer. Elevated IL-6 concentrations are associated with an increased risk of death in patients with and without cancer.
After Guruji’s blessing this factor has shown significant drop up to 98.8%
3) Prostate-Specific Antigen (PSA)
PSA is a protein made by normal cells and prostate cancer cells. Doctors often use a score of 4 nanograms (ng) or higher as the trigger for further tests, such as a prostate biopsy. This serum component has been used to track the response to therapy in men with prostate cancer. A pattern of PSA rise after local therapy distinguishes between local and distant recurrence. Distant disease can be predicted if the PSA does not become undetectable following radical prostatectomy, begins to rise within 12 months, or has a doubling time of 6 months. Patients whose PSA level becomes detectable 24 months or more after radical prostatectomy likely have local recurrence. Patients with PSA doubling times of 12 months or more following surgery, radiation therapy, or cryotherapy are likely to have local recurrence.
PSA levels can rise if a man has prostate cancer, but a high PSA is not proof of cancer. The advent of PSA testing has revolutionized the diagnosis of prostate cancer and has provided a powerful tool to assess the effects of therapy. Although PSA cannot be used to diagnose prostate cancer and is not a specific prostate cancer marker, the benefits of PSA testing outweigh its drawbacks.
Interestingly, all above changes have been observed only within 10 days. Though this study, Guruji has provided a model that will definitely help the scientists to discover the possible mechanisms that cause cancer.
We are happy to welcome all research organizations that are willing to conduct more research on cancer and related disorders. The data presented here would definitely prove the presence of an unknown energy though Gurujis body which has caused such a significant changes in such a short span of 10 days.
|
